Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1013 studies found for:    Huntington's Disease
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Other: Placebo;   Drug: Dimebon
2 Unknown  Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
Condition: Huntington Disease
Intervention:
3 Active, not recruiting Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition: Huntington Disease
Intervention: Drug: pridopidine
4 Completed A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: Pridopidine;   Other: Placebo
5 Completed A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
Condition: Huntington's Disease
Intervention: Drug: SEN0014196
6 Completed An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Condition: Huntington Disease
Interventions: Drug: SEN0014196 (Low Dose);   Drug: SEN0014196 (High Dose);   Drug: Placebo
7 Terminated Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea
Conditions: Huntington's Disease;   Chorea
Interventions: Drug: AFQ056;   Drug: Placebo
8 Recruiting Study of Biomarkers That Predict the Evolution of Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Huntington patient evaluation;   Other: Healthy subject evaluation
9 Completed Family Health After Predictive Huntington Disease (HD) Testing
Condition: Huntington Disease
Intervention: Genetic: Mutation in the gene
10 Completed Caregiver Burden in Huntington's Disease
Condition: Caregiver of Huntington's Disease Patient
Intervention: Other: ZARIT Burden Interview
11 Recruiting Exercise Effects in Huntington's Disease
Condition: Huntington's Disease
Intervention: Behavioral: Exercise training
12 Completed Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Dimebon
13 Completed A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: ACR16;   Drug: Placebo
14 Completed A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ACR16 10 mg;   Drug: ACR16 22.5 mg;   Drug: ACR16 45 mg;   Other: Placebo
15 Not yet recruiting PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease
Condition: Huntington's Disease
Intervention: Device: Deep Brain Stimulation
16 Active, not recruiting Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
Condition: Huntington Disease
Intervention:
17 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
18 Completed
Has Results
Pilot Study of Minocycline in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: minocycline;   Drug: Matching placebo
19 Completed TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Ethyl-EPA (Miraxion™)
20 Completed Creatine Therapy for Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Creatine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.